Covered recipient · General Payments record
SABRINA LEWIS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,987.35
- Reported across 152 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $450.40 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $194.94 | 5 |
| Amgen Inc. | $77.23 | 4 |
| Novo Nordisk AS | $52.81 | 3 |
| GlaxoSmithKline, LLC. | $30.82 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $28.92 | 1 |
| ABBVIE INC. | $28.65 | 1 |
| Exact Sciences Corporation | $21.56 | 1 |
| Esperion Therapeutics, Inc. | $15.47 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.65 | 07/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107536095 | CMS |
| Amgen Inc. | $20.77 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117610887 | CMS |
| Amgen Inc. | $19.72 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117610889 | CMS |
| Amgen Inc. | $17.87 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117610891 | CMS |
| Amgen Inc. | $18.87 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117610893 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $28.92 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118128567 | CMS |
| Esperion Therapeutics, Inc. | $15.47 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129471018 | CMS |
| Exact Sciences Corporation | $21.56 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114756454 | CMS |
| GlaxoSmithKline, LLC. | $14.82 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116278956 | CMS |
| GlaxoSmithKline, LLC. | $16.00 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116360466 | CMS |
| Lilly USA, LLC | $121.84 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135883827 | CMS |
| Lilly USA, LLC | $17.68 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135939890 | CMS |
| Lilly USA, LLC | $16.09 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135901984 | CMS |
| Lilly USA, LLC | $19.60 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135956085 | CMS |
| Lilly USA, LLC | $19.73 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135935304 | CMS |
| Novo Nordisk Inc | $19.38 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100461872 | CMS |
| Novo Nordisk Inc | $17.49 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100441449 | CMS |
| Novo Nordisk Inc | $15.94 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100590134 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.